Anticoagulation in sepsis: Is low-dose heparin as effective as activated protein C?

被引：10

作者：

Agarwal, R ^{[1
]}

Gupta, D ^{[1
]}

机构：

[1] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India

来源：

INTENSIVE CARE MEDICINE | 2005年 / 31卷 / 09期

关键词：

D O I：

10.1007/s00134-005-2723-0

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1297 / 1298

页数：2

共 8 条

[1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[2]

*ANT ADV COMM, 2001, 12502900 BLA FDA ANT

[3] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[4] INHIBITION OF COMPLEMENT DEPENDENT EXPERIMENTAL INFLAMMATION IN HUMAN-SKIN BY DIFFERENT HEPARIN FRACTIONS [J].

EKRE, HPT ;

FJELLNER, B ;

HAGERMARK, O .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (03) :277-286

[5] Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma [J].

Fath, MA ;

Wu, XJ ;

Hileman, RE ;

Linhardt, RJ ;

Kashem, MA ;

Nelson, RM ;

Wright, CD ;

Abraham, WM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13563-13569

[6] INHIBITION OF LYMPHOCYTE-T HEPARANASE BY HEPARIN PREVENTS T-CELL MIGRATION AND T-CELL-MEDIATED IMMUNITY [J].

LIDER, O ;

MEKORI, YA ;

MILLER, T ;

BARTANA, R ;

VLODAVSKY, I ;

BAHARAV, E ;

COHEN, IR ;

NAPARSTEK, Y .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (03) :493-499

[7]

MATZNER Y, 1984, THROMB HAEMOSTASIS, V52, P1134

[8] High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial [J].

Warren, BL ;

Eid, A ;

Singer, P ;

Pillay, SS ;

Carl, P ;

Novak, I ;

Chalupa, P ;

Atherstone, A ;

Pénzes, I ;

Kübler, A ;

Knaub, S ;

Keinecke, HO ;

Heinrichs, H ;

Schindel, F ;

Juers, M ;

Bone, RC ;

Opal, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1869-1878

← 1 →